col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


150 Results       Page 1

 [1] 
Springer-Verlag: Rheumatology International
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―29 Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases Alexandros Panagiotopoulos, George E. Fragoulis, Aikaterini Arida, Vassiliki-Kalliopi Bournia, Gerasimos Evangelatos, Kalliopi Fragkiadaki, et al. (+12)
2 [GO] 2024―Mar―12 Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study Cristiana Sieiro Santos, Jun-Peng Chen, Elena Nikiphorou, Chi-Wei Tseng, Carlos Enrique Toro Gutiérrez, Ai Lyn Tan, et al. (+180)
3 [GO] 2024―Feb―23 Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic Tatjana Zekić, Andrej Belančić
4 [GO] 2024―Feb―06 Telerehabilitation: lessons from the COVID-19 pandemic and future perspectives Burhan Fatih Kocyigit, Meirgul I. Assylbek, Marlen Yessirkepov
5 [GO] 2024―Jan―23 Post-stroke rehabilitation in the peri-pandemic COVID-19 era Meirgul I. Assylbek, Burhan Fatih Kocyigit, Marlen Yessirkepov, Olena Zimba
6 [GO] 2023―Dec―24 Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anic, Robert Likic
7 [GO] 2023―Dec―07 COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group Suhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, Arvind Nune, Mahnoor Javaid, Abraham Edgar Gracia-Ramos, et al. (+183)
8 [GO] 2023―Oct―31 SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey Ramnath Misra, Debdutta Bhattacharya, Sakir Ahmed, Sanjiv Amin, Vineeta Shobha, Alakendu Ghosh, et al. (+8)
9 [GO] 2023―Oct―28 COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China Chen Chen, Saisai Huang, Linyu Geng, Peng Lai, Huan Dou, Huayong Zhang, et al. (+3)
10 [GO] 2023―Oct―06 Reactive arthritis following COVID-19: clinical case presentation and literature review Dana Bekaryssova, Marlen Yessirkepov, Sholpan Bekarissova
11 [GO] 2023―Sep―30 The COVID-19 pandemic’s impact on rheumatic disease patients’ satisfaction with access to medical services Aleksandar Marinkov, Rositsa Dimova, Rositsa Karalilova, Donka Keskinova, Dimitar Bahariev, Konstantin Batalov, et al. (+3)
12 [GO] 2023―Sep―26 The presumed protective effect of IVIG against SARS-CoV-2 in inflammatory myopathy patients remains questionable Josef Finsterer, Fulvio A. Scorca
13 [GO] 2023―Sep―25 Revisiting articular syndrome in the peri-pandemic COVID-19 era Dana Bekaryssova, Prakashini Mruthyunjaya Vijaya, Sakir Ahmed, Suhas Sondur, Olena Zimba
14 [GO] 2023―Sep―15 Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort Suhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, Akira Yoshida, Keina Yomono, John D. Pauling, et al. (+20)
15 [GO] 2023―Sep―13 Familial Mediterranean fever during and post-COVID-19 pandemic Farhad Salehzadeh
16 [GO] 2023―Sep―11 Ongoing shielding behavior one year post COVID-19: results from a longitudinal study of patients with inflammatory arthritis Melissa Sweeney, Lewis Carpenter, Savia de Souza, Hema Chaplin, Hsiu Tung, Emma Caton, et al. (+5)
17 [GO] 2023―Sep―05 Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey Sakir Ahmed, Latika Gupta, Masataka Kuwana, John D. Pauling, Jessica Day, Naveen Ravichandran, et al. (+102)
18 [GO] 2023―Aug―10 The impact of COVID-19 related lockdown restrictions on musculoskeletal health: a systematic review Tadesse Gebrye, Faatihah Niyi-Odumosu, Joyceline Lawoe, Chidozie Mbada, Francis Fatoye
19 [GO] 2023―Aug―05 Long COVID: the time has come for globally acceptable definitions Chokan Baimukhamedov, Khilola Mirakhmedova, Gulzhan Dossybayeva
20 [GO] 2023―Jul―12 New insights into epidemiological data and impact of the COVID-19 pandemic on IgA vasculitis in children and adults: a French nationwide cohort Valentin Maisons, Yanis Ramdani, Antoine Hankard, Claude Messiaen, Anne-Sophie Jannot, Bénédicte Sautenet, et al. (+4)
21 [GO] 2023―Jun―27 Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin Sangmee Sharon Bae, Emmanuelle Faure-Kumar, Kathie Ferbas, Jennifer Wang, Ani Shahbazian, Linh Truong, et al. (+4)
22 [GO] 2023―Jun―23 Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico Pamela Munguía-Realpozo, Claudia Mendoza-Pinto, Ivet Etchegaray-Morales, Juan Carlos Solis-Poblano, Jorge Ayón-Aguilar, Edith Ramírez-Lara, et al. (+3)
23 [GO] 2023―Jun―20 Femoral head avascular necrosis in COVID-19 survivors: a systematic review Ahmed Abdelazim A. Hassan, Ahmed A. Khalifa
24 [GO] 2023―Jun―13 Predictors of a weak antibody response to COVID-19 mRNA vaccine in systemic lupus erythematosus Christine Parsons, Jose Rubio, Afroditi Boulougoura, Suzanne Krishfield, Vasileios Kyttaris
25 [GO] 2023―May―02 The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study Alfonso Gastelum-Strozzi, Diana Elsa Flores-Alvarado, Virginia Pascual-Ramos, Everardo Álvarez-Hernández, César Francisco Pacheco-Tena, Guillermo Arturo Guaracha-Basáñez, et al. (+10)
26 [GO] 2023―Apr―25 Osteonecrosis amid the COVID-19 pandemic Chokan Baimukhamedov, Aliya Botabekova, Zhanyl Lessova, Bekzhat Abshenov, Nursezim Kurmanali
27 [GO] 2023―Apr―04 Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey R. Naveen, Darpan R. Thakare, Masataka Kuwana, John D. Pauling, Jessica Day, Mrudula Joshi, et al. (+103)
28 [GO] 2023―Mar―30 Long COVID in autoimmune rheumatic diseases Yuliya Fedorchenko, Olena Zimba
29 [GO] 2023―Mar―29 Unauthorized change of immunosuppressants by patients with rheumatic diseases in the COVID-19 pandemic: a cross-sectional analysis of a patient survey Simon Dahm, Joerg C. Henes, Sebastian J. Saur
30 [GO] 2023―Mar―14 Burnout in South Asian rheumatologists in the COVID-19 pandemic: an online survey Tayyeba Khursheed, Muhammad Sharif, Muhammad Sufyan Khan, Ahmed Masood, Wajahat Aziz, Somaya Shah, et al. (+2)
31 [GO] 2023―Feb―17 A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19 Koushan Kouranloo, Mrinalini Dey, Helen Elwell, Arvind Nune
32 [GO] 2023―Jan―16 The impact of the COVID-19 pandemic on patients with systemic vasculitis: a single-centre retrospective study Akerke Auanassova, Marlen Yessirkepov, Olena Zimba
33 [GO] 2022―Dec―30 Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity Aparna R. Menon, Somy Cherian, Aby Paul, Kripesh Kumar, Sakir Ahmed, Pankti Mehta, et al. (+4)
34 [GO] 2022―Oct―22 COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey Leonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, Jessica Day, Parikshit Sen, Jucier Gonçalves Junior, et al. (+35)
35 [GO] 2022―Oct―18 Impact of COVID-19 pandemic on rheumatology trainees: an online survey Kunal Chandwar, Sayan Mukherjee, Digvijay Ekbote, Kriti Kishor, Prasanna Dogga, Juhi Dixit, et al. (+2)
36 [GO] 2022―Sep―13 New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review Iftach Sagy, Lior Zeller, Yael Raviv, Tzvika Porges, Amir Bieber, Mahmoud Abu-Shakra
37 [GO] 2022―Aug―08 New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review Marie-Therese Holzer, Martin Krusche, Nikolas Ruffer, Heinrich Haberstock, Marlene Stephan, Tobias B. Huber, Ina Kötter
38 [GO] 2022―Aug―02 Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study Joydeep Samanta, GSRSNK Naidu, Prateek Deo, Sakshi Mittal, Chandra Bhushan Prasad, Diganta Das, et al. (+8)
39 [GO] 2022―Jul―02 Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome Ayse Ozdede, Okan Kadir Nohut, Zeynep Atli, Yeşim Tuyji Tok, Sabriye Guner, Erkan Yilmaz, et al. (+4)
40 [GO] 2022―Jun―13 Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature Cristina Valero, Juan Pablo Baldivieso-Achá, Miren Uriarte, Esther F. Vicente-Rabaneda, Santos Castañeda, Rosario García-Vicuña
41 [GO] 2022―Jun―04 Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review Daniel Gonzalez, Latika Gupta, Vijaya Murthy, Emilio B. Gonzalez, Katrina A. Williamson, Ashima Makol, et al. (+6)
42 [GO] 2022―May―03 The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, George Kollias, Petros P. Sfikakis
43 [GO] 2022―Apr―16 Rheumatologists’ knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey Hanan M. Fathi, Iman I. El Gazzar, Mervat I. Abd Elazeem, Enas AboulKheir, Nada M. Gamal, Faten Ismail, et al. (+23)
44 [GO] 2022―Apr―16 Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis Martin Feuchtenberger, Magdolna Szilvia Kovacs, Anna Eder, Axel Nigg, Arne Schäfer
45 [GO] 2022―Apr―12 A better but persistently low health status in women with fibromyalgia during the COVID-19 pandemic: a repeated cross-sectional data analysis Tim Y. Koppert, Henriët van Middendorp, Rinie Geenen
46 [GO] 2022―Apr―11 Technical factors can impact on remote consultations in rheumatology: results from a service evaluation during the COVID-19 pandemic Sreekanth Vasireddy, Surabhi Wig, Michael Hannides
47 [GO] 2022―Apr―04 Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine Ayse Ozdede, Sabriye Guner, Guzin Ozcifci, Berna Yurttas, Zeynep Toker Dincer, Zeynep Atli, et al. (+8)
48 [GO] 2022―Mar―31 Isolation in patients with inflammatory rheumatic diseases during COVID-19 pandemic compared to healthy individuals: a questionnaire survey Tobias Eschricht Eriksen, Wilfred K. H. Dinesen, Line Uhrenholt, Lene Dreyer, Kirsten Duch, Salome Kristensen
49 [GO] 2022―Mar―11 Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review Ophir Freund, Tali Eviatar, Gil Bornstein
50 [GO] 2022―Feb―14 The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey Abdulvahap Kahveci, Alper Gümüştepe, Nurhan Güven, Şebnem Ataman
51 [GO] 2022―Feb―05 ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review Arun Prabhahar, G. S. R. S. N. K. Naidu, Prabhat Chauhan, Aravind Sekar, Aman Sharma, Alok Sharma, et al. (+5)
52 [GO] 2022―Jan―20 Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination Ekaterina Kurteva, Georgi Vasilev, Kalina Tumangelova-Yuzeir, Irena Ivanova, Ekaterina Ivanova-Todorova, Tsvetelina Velikova, Dobroslav Kyurkchiev
53 [GO] 2022―Jan―13 Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review Anna Masiak, Amanda Lass, Jacek Kowalski, Adam Hajduk, Zbigniew Zdrojewski
54 [GO] 2021―Nov―30 Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study Christopher Balchin, Ai Lyn Tan, Oliver J. Wilson, Jim McKenna, Antonios Stavropoulos-Kalinoglou
55 [GO] 2021―Nov―25 The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome Guzin Ozcifci, Tahacan Aydin, Zeynep Atli, Ilker Inanc Balkan, Fehmi Tabak, Mert Oztas, et al. (+7)
56 [GO] 2021―Nov―19 A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient Young Hun Jeon, Doo-Ho Lim, Seung Won Choi, Su Jin Choi
57 [GO] 2021―Nov―15 COVID-19 vaccination in autoimmune disease (COVAD) survey protocol Parikshit Sen, Latika Gupta, James B. Lilleker, Vishwesh Aggarwal, Sinan Kardes, Marcin Milchert, et al. (+79)
58 [GO] 2021―Nov―05 Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America Daniel G. Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, Sergio Kowalski, Ana Sapag, Antonio Cachafeiro-Vilar, et al. (+16)
59 [GO] 2021―Nov―05 COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study George E. Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, Gerasimos Evangelatos, Kalliopi Fragiadaki, Anastasios Karamanakos, et al. (+8)
60 [GO] 2021―Nov―02 Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases Ummusen Kaya Akca, Erdal Atalay, Muserref Kasap Cuceoglu, Zeynep Balik, Seher Sener, Yasemin Ozsurekci, et al. (+4)
61 [GO] 2021―Oct―19 Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study Narendra Kumar Bagri, Rakesh Kumar Deepak, Suneeta Meena, Saurabh Kumar Gupta, Satya Prakash, Kritika Setlur, et al. (+8)
62 [GO] 2021―Oct―15 Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic Yashdeep Singh Pathania
63 [GO] 2021―Oct―08 Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study Jorge Antonio Esquivel-Valerio, Cassandra Michele Skinner-Taylor, Ilse Andrea Moreno-Arquieta, Jesus Alberto Cardenas-de la Garza, Gisela Garcia-Arellano, Patricia Ludivina Gonzalez-Garcia, et al. (+2)
64 [GO] 2021―Oct―01 COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis Bohdana Doskaliuk, Roman Yatsyshyn, Iryna Klishch, Olena Zimba
65 [GO] 2021―Sep―27 Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes Tuba Güler, Fatma Gül Yurdakul, Filiz Acar Sivas, Zeynep Kiliç, Emre Adigüzel, Evren Yaşar, Hatice Bodur
66 [GO] 2021―Sep―27 The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study Betul Sozeri, Kadir Ulu, Ummusen Kaya-Akça, Fatih Haslak, Aysenur Pac-Kisaarslan, Gulcin Otar-Yener, et al. (+24)
67 [GO] 2021―Sep―25 YouTube as a source of information on COVID-19 vaccination in rheumatic diseases Burhan Fatih Kocyigit, Ahmet Akyol
68 [GO] 2021―Sep―22 Reactive arthritis after COVID-19: a case-based review Burhan Fatih Kocyigit, Ahmet Akyol
69 [GO] 2021―Sep―13 Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls Ali Mert, Haluk Vahaboğlu, Ferhat Arslan, Ayşe Batirel, Kemal Tolga Saraçoğlu, Aliye Bastug, et al. (+38)
70 [GO] 2021―Sep―08 A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany Rebecca Hasseli, Alexander Pfeil, Andreas Krause, Hendrik Schulze-Koops, Ulf Müller-Ladner, Christof Specker, et al. (+8)
71 [GO] 2021―Sep―03 Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis Lars Erik Bartels, Christian Ammitzbøll, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbæk Mistegaard, Anders Dahl Johannsen, et al. (+5)
72 [GO] 2021―Aug―28 COVID-19 and fertility-at the crossroads of autoimmunity and thrombosis Javeria Tariq, Tulika Chatterjee, Laura Andreoli, Latika Gupta
73 [GO] 2021―Aug―28 The impact of the COVID-19 pandemic on patients with primary sjögren syndrome Augustin Serban, Ancuta Mihai, Alina Dima, Daniel Vasile Balaban, Mariana Jinga, Ciprian Jurcut
74 [GO] 2021―Aug―24 Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey Chirag Rajkumar Kopp, GSRSNK Naidu, Durga Prasanna Misra, Prateek Deo, Roopesh Sai Jakulla, Kavita Makan, et al. (+3)
75 [GO] 2021―Aug―19 Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed Dimitrios Daoussis, Lydia Leonidou, Christina Kalogeropoulou, Fotini Paliogianni, Argyrios Tzouvelekis
76 [GO] 2021―Aug―02 Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry Jing Li, Sarah Ringold, Jeffrey R. Curtis, Kaleb Michaud, Tracy Johansson, Huifeng Yun, et al. (+2)
77 [GO] 2021―Jul―23 Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown Grace Johnstone, Gareth J. Treharne, Benjamin D. Fletcher, Roisin S. M. Lamar, Douglas White, Andrew Harrison, Simon Stebbings
78 [GO] 2021―Jul―22 Correction to: COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Bahar Özdemir, Abdulsamet Erden, Serdar Can Güven, Berkan Armagan, Hakan Apaydin, Özlem Karakas, et al. (+4)
79 [GO] 2021―Jul―22 Correction to: Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection Sibabratta Patnaik, Mukesh Kumar Jain, Sakir Ahmed, Arun Kumar Dash, Ram Kumar P, Bandya Sahoo, et al. (+2)
80 [GO] 2021―Jul―14 Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection Sibabratta Patnaik, Mukesh Kumar Jain, Sakir Ahmed, Arun Kumar Dash, Ram Kumar P, Bandya Sahoo, et al. (+2)
81 [GO] 2021―Jul―09 Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt Nevin Hammam, Samar Tharwat, Rawhya R. El Shereef, Ahmed M. Elsaman, Noha M. Khalil, Hanan M. Fathi, et al. (+29)
82 [GO] 2021―Jul―02 COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey Priyanka Gaur, Hardik Agrawat, Anuj Shukla
83 [GO] 2021―Jun―17 Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey Somy Cherian, Aby Paul, Sakir Ahmed, Bazil Alias, Manesh Manoj, Ansu K. Santhosh, et al. (+3)
84 [GO] 2021―Jun―10 Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective Javeria Tariq, Latika Gupta
85 [GO] 2021―Jun―09 Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly Emire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, Mert Ahmet Kuskucu, Yesim Tok, Necdet Sut, et al. (+6)
86 [GO] 2021―Jun―07 ANCA-associated vasculitis after COVID-19 Tugba Izci Duran, Ercan Turkmen, Melda Dilek, Hayriye Sayarlioglu, Nurol Arik
87 [GO] 2021―Jun―06 COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review Alicia Rodriguez-Pla, Holenarasipur R. Vikram, Vanood Khalid, Lewis J. Wesselius
88 [GO] 2021―Jun―05 COVID-19 in patients with gout on colchicine Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari, Alexandros A. Drosos
89 [GO] 2021―May―25 COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Bahar Özdemir, Abdulsamet Erden, Serdar Can Güven, Berkan Armagan, Hakan Apaydin, Özlem Karakas, et al. (+4)
90 [GO] 2021―May―25 The impact of COVID-19 on familial Mediterranean fever: a nationwide study Zafer Günendi, Fatma Gül Yurdakul, Hatice Bodur, Ahmet Kıvanç Cengiz, Ülkü Uçar, Hasan Fatih Çay, et al. (+20)
91 [GO] 2021―May―12 Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş
92 [GO] 2021―May―05 Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study Mostafa Najim, Alaa Rahhal, Fadi Khir, Amer Hussien Aljundi, Safae Abu Yousef, Feryal Ibrahim, et al. (+9)
93 [GO] 2021―May―04 Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting Michel Chevallard, Laura Belloli, Nicola Ughi, Antonella Adinolfi, Cinzia Casu, Maria Di Cicco, et al. (+12)
94 [GO] 2021―Apr―26 Sex hormones, autoimmunity and gender disparity in COVID-19 Hussain Ahmed Raza, Parikshit Sen, Omaima Anis Bhatti, Latika Gupta
95 [GO] 2021―Apr―15 Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases Zeyad A. Alzahrani, Khalid Abdullah Alghamdi, Ahmed Saeed Almaqati
96 [GO] 2021―Apr―12 COVID-19 pandemic and systemic autoinflammatory diseases management: a cross-sectional survey Na Wu, Mengzhu Zhao, Di Wu, Keyi Yu, Min Shen
97 [GO] 2021―Mar―29 Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey Berna Yurttas, Burc Cagri Poyraz, Necdet Sut, Ayse Ozdede, Mert Oztas, Serdal Uğurlu, et al. (+3)
98 [GO] 2021―Mar―27 Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry Pankti Mehta, Pedro M. Machado, Latika Gupta
99 [GO] 2021―Mar―19 Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent Aliye Bastug, Halide Aslaner, Yesim Aybar Bilir, Nizamettin Kemirtlek, Fahriye Melis Gursoy, Serdal Bastug, Hurrem Bodur
100 [GO] 2021―Mar―12 Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions Ansh Bhatia, Manish KC, Latika Gupta
101 [GO] 2021―Mar―09 Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis Qingxiu Wang, Jianbo Liu, Runxia Shao, Xiaopeng Han, Chenhao Su, Wenjia Lu
102 [GO] 2021―Mar―08 Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists Ales Janda, Catharina Schuetz, Scott Canna, Mark Gorelik, Maximilian Heeg, Kirsten Minden, et al. (+5)
103 [GO] 2021―Mar―05 Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19 Nourhane Nasser, Mazen Kurban, Ossama Abbas
104 [GO] 2021―Mar―04 Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study George E. Fragoulis, Ioannis Grigoropoulos, Evgenia Mavrea, Aikaterini Arida, Vassiliki-Kalliopi Bournia, Gerasimos Evangelatos, et al. (+10)
105 [GO] 2021―Mar―03 Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience Michalis P. Migkos, Evripidis Kaltsonoudis, Eleftherios Pelechas, Vassiliki Drossou, Panagiota G. Karagianni, Athanasios Kavvadias, et al. (+2)
106 [GO] 2021―Feb―21 COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review Kemal Nas, Nuran Eryilmaz, Mehmet Faruk Geyik, Ayfer Altaş
107 [GO] 2021―Feb―21 COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study Serdar Can Güven, Abdulsamet Erden, Özlem Karakaş, Berkan Armağan, Eren Usul, Ahmet Omma, Orhan Küçükşahin
108 [GO] 2021―Feb―10 The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding N. Cleaton, S. Raizada, N. Barkham, S. Venkatachalam, T. P. Sheeran, T. Adizie, et al. (+3)
109 [GO] 2021―Feb―04 Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review Abraham Edgar Gracia-Ramos, Miguel Ángel Saavedra-Salinas
110 [GO] 2021―Jan―30 SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis Tsvetelina Velikova, Tsvetoslav Georgiev
111 [GO] 2021―Jan―27 Enhancing rheumatology education during the COVID-19 pandemic Saira Bilal, Victoria K. Shanmugam
112 [GO] 2021―Jan―27 Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents Gizem Durcan, Kenan Barut, Fatih Haslak, Hilal Doktur, Mehmet Yildiz, Amra Adrovic, et al. (+2)
113 [GO] 2021―Jan―15 Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands Wouter H. Bos, Astrid van Tubergen, Harald E. Vonkeman
114 [GO] 2021―Jan―03 Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic Sakir Ahmed, Armen Yuri Gasparyan, Olena Zimba
115 [GO] 2021―Jan―03 Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis-ITIE” Emre Bilgin, Ali İhsan Ertenli
116 [GO] 2021―Jan―02 Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19 Chia Siang Kow, Syed Shahzad Hasan
117 [GO] 2021―Jan―01 COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases Hussain Ahmed Raza, Javeria Tariq, Vikas Agarwal, Latika Gupta
118 [GO] 2020―Nov―30 Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19 Sophia M. Brady, Sally A. M. Fenton, George S. Metsios, Ailsa Bosworth, Joan L. Duda, George D. Kitas, Jet J. C. S. Veldhuijzen van Zanten
119 [GO] 2020―Nov―21 Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management Jayakanthan Kabeerdoss, Rakesh Kumar Pilania, Reena Karkhele, T. Sathish Kumar, Debashish Danda, Surjit Singh
120 [GO] 2020―Nov―17 COVID-19 pandemic in Japan Olga Amengual, Tatsuya Atsumi
121 [GO] 2020―Nov―07 Building trust in journals and in peer review: need of the hour during the COVID-19 pandemic Sakir Ahmed
122 [GO] 2020―Nov―04 Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic R. Naveen, T. G. Sundaram, Vikas Agarwal, Latika Gupta
123 [GO] 2020―Nov―01 Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient Esam Abualfadl, Faten Ismail, Rawhya R. El Shereef, Eman Hassan, Samar Tharwat, Eman F. Mohamed, et al. (+14)
124 [GO] 2020―Oct―18 COVID-19 in Italian Sjögren's syndrome patients: a monocentric study F. Giardina, R. Izzo, A. Gattamelata, S. Colafrancesco, F. Conti, R. Priori
125 [GO] 2020―Oct―18 Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends Sinan Kardeş, Ali Suat Kuzu, Rahul Raiker, Haig Pakhchanian, Mine Karagülle
126 [GO] 2020―Oct―13 Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists Latika Gupta, Armen Yuri Gasparyan, Olena Zimba, Durga Prasanna Misra
127 [GO] 2020―Oct―12 Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease Chia Siang Kow, Syed Shahzad Hasan
128 [GO] 2020―Sep―29 #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic Nikolas Ruffer, Johannes Knitza, Martin Krusche
129 [GO] 2020―Sep―18 High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study Jesús Loarce-Martos, Antía García-Fernández, Fernando López-Gutiérrez, Verónica García-García, Laura Calvo-Sanz, Iván del Bosque-Granero, et al. (+4)
130 [GO] 2020―Sep―16 Kawasaki-like disease in children with COVID-19 Ummusen Kaya Akca, Selman Kesici, Yasemin Ozsurekci, Hayrettin Hakan Aykan, Ezgi Deniz Batu, Erdal Atalay, et al. (+6)
131 [GO] 2020―Sep―15 Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases Vladimira Vasileva Boyadzhieva, Nikolay Rumenov Stoilov, Rumen Malinov Stoilov
132 [GO] 2020―Aug―13 Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes Fernando Montero, Julia Martínez-Barrio, Belén Serrano-Benavente, Teresa González, Javier Rivera, Juan Molina Collada, et al. (+2)
133 [GO] 2020―Aug―02 Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19 Oya Koker, Fatma Gul Demirkan, Gulsah Kayaalp, Figen Cakmak, Ayse Tanatar, Serife Gul Karadag, et al. (+3)
134 [GO] 2020―Jul―24 Rheumatologists’ practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt Tamer A. Gheita, Mohamed N. Salem, Nahla N. Eesa, Noha M. Khalil, Nada M. Gamal, Rasha Abdel Noor, et al. (+26)
135 [GO] 2020―Jul―14 Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic Francesco Masini, Klodian Gjeloshi, Roberta Ferrara, Emanuele Pinotti, Giovanna Cuomo
136 [GO] 2020―Jul―14 Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment Sanket Shah, Debashish Danda, Chengappa Kavadichanda, Saibal Das, M. B. Adarsh, Vir Singh Negi
137 [GO] 2020―Jul―13 Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic Fatih Haslak, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Oya Koker, Ayten Aliyeva, et al. (+2)
138 [GO] 2020―Jul―11 Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes Efstathios Kastritis, George D. Kitas, Dimitrios Vassilopoulos, Georgios Giannopoulos, Meletios A. Dimopoulos, Petros P. Sfikakis
139 [GO] 2020―Jun―26 Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review Ilke Coskun Benlidayi, Behice Kurtaran, Emre Tirasci, Rengin Guzel
140 [GO] 2020―Jun―25 Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic Mehmet Soy, Pamir Atagündüz, Işık Atagündüz, Gülsan Türköz Sucak
141 [GO] 2020―Jun―22 The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey Emire Seyahi, Burc Cagri Poyraz, Necdet Sut, Selma Akdogan, Vedat Hamuryudan
142 [GO] 2020―Jun―12 Targeting the immunology of coronavirus disease-19: synchronization creates symphony Sakir Ahmed, Prajna Anirvan
143 [GO] 2020―Jun―08 Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic Zaure Mukusheva, Maikesh Assylbekova, Dimitri Poddighe
144 [GO] 2020―Jun―04 Implications of COVID-19 in pediatric rheumatology Ezgi Deniz Batu, Seza Özen
145 [GO] 2020―Jun―02 Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic Hyun-Sook Kim, Myeung-Su Lee, HyungJin Kim, Yoon-Kyoung Sung, Jisoo Lee, Seung-Cheol Shim, et al. (+2)
146 [GO] 2020―May―15 Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19) Erkan Cure, Adem Kucuk, Medine Cumhur Cure
147 [GO] 2020―Apr―20 Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs Jehun Song, Seongmin Kang, Seung Won Choi, Kwang Won Seo, Sunggun Lee, Min Wook So, Doo-Ho Lim
148 [GO] 2020―Mar―30 Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs Tsvetoslav Georgiev
149 [GO] 2020―Mar―30 COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone
150 [GO] 2020―Mar―28 Arthralgia as an initial presentation of COVID-19: observation Beuy Joob, Viroj Wiwanitkit
 [1] 

150 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec